Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1.
about
Role of advanced glycation end products in cellular signalingAdvanced glycation end products and oxidative stress in type 2 diabetes mellitus.Glycated human serum albumin isolated from poorly controlled diabetic patients impairs cholesterol efflux from macrophages: an investigation by mass spectrometry.Effect of liposome-encapsulated hemoglobin resuscitation on proteostasis in small intestinal epithelium after hemorrhagic shock.The Immunoproteasome in oxidative stress, aging, and disease.Protective effects of physiological testosterone on advanced glycation end product‑induced injury in human endothelial cells.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.The proteasome and the degradation of oxidized proteins: part III-Redox regulation of the proteasomal system.Impaired proteostasis: role in the pathogenesis of diabetes mellitus.The proteasome and the degradation of oxidized proteins: Part II - protein oxidation and proteasomal degradation.Establishment of a suite of assays that support the discovery of proteasome stimulators.Differential Receptor for Advanced Glycation End Products Expression in Preeclamptic, Intrauterine Growth Restricted, and Gestational Diabetic Placentas.Macroautophagy is impaired in old murine brain tissue as well as in senescent human fibroblasts.In type 2 diabetes mellitus glycated albumin alters macrophage gene expression impairing ABCA1-mediated cholesterol efflux.Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies
P2860
Q27003423-F8EC6F1A-61AF-47FC-8A17-EDBAF1787142Q35255473-22BC6578-4004-4506-A248-5657BB0C43FFQ35755524-5211559D-C91C-4CF9-A80C-FA82721D0CA6Q37139518-589C2AF4-356C-42B2-AC22-BABFD6D6470FQ37141580-EEE519DF-A7AC-4810-937C-0A25EFB7F9D6Q37722123-19F02F7D-09E8-4020-8963-3FEC80156C4FQ38096444-84729A7A-0128-4A7A-A562-A7D207C9F062Q38108373-375E099B-6F08-4F73-8BDA-CD449160F947Q38190556-3F805226-BE73-424D-8CCE-E8F0A2CCC62CQ38210860-C4548FAB-DC99-4588-8613-B4BCE43CD6FCQ38280561-0BE0CF9D-8659-4851-B4D0-B265B63F067AQ38433969-4EF24AE2-E866-4252-9607-FB4C4606E975Q38810728-BF5B848E-72EA-49F0-B009-C5BA9DA9024BQ42372625-2099B4B1-8EF9-4C1A-9556-A7FDF967C4C8Q54308663-134BFCFF-85F6-4E3C-8DF0-0B8327C5B893Q58577346-17F462F7-3C28-44E0-9E0B-46103F85A09C
P2860
Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Advanced-glycation-end-product ...... vement of RAGE and Jak2/STAT1.
@en
Advanced-glycation-end-product ...... vement of RAGE and Jak2/STAT1.
@nl
type
label
Advanced-glycation-end-product ...... vement of RAGE and Jak2/STAT1.
@en
Advanced-glycation-end-product ...... vement of RAGE and Jak2/STAT1.
@nl
prefLabel
Advanced-glycation-end-product ...... vement of RAGE and Jak2/STAT1.
@en
Advanced-glycation-end-product ...... vement of RAGE and Jak2/STAT1.
@nl
P2860
P50
P356
P1433
P1476
Advanced-glycation-end-product ...... lvement of RAGE and Jak2/STAT1
@en
P2093
Melanie Hörlacher
Stefanie Grimm
P2860
P304
P356
10.1042/BJ20120298
P407
P577
2012-11-01T00:00:00Z